Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Sarah Kennedy: Calocurb CEO on Wegovy becoming available in New Zealand

4:27
 
Share
 

Manage episode 491058998 series 2098280
Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Access is opening up for Kiwis to a weight loss drug described as a game changer.

Wegovy, made by pharma-co Novo Nordisk, will arrive in pharmacies next week.

It's not funded by Pharmac, so users will have to pay and get a prescription for the weekly injectable.

Calocurb CEO Sarah Kennedy told Ryan Bridge that people need to be aware of both the cost of the drug and the side effect.

She says that over 70% of people using Wegovy will have gastrointestinal problems that range from nausea to diarrhoea, and over 70% of people regain the weight within a year.

Kennedy says lifestyle changes need to be made as well as taking the drug.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

4104 episodes

Artwork
iconShare
 
Manage episode 491058998 series 2098280
Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Access is opening up for Kiwis to a weight loss drug described as a game changer.

Wegovy, made by pharma-co Novo Nordisk, will arrive in pharmacies next week.

It's not funded by Pharmac, so users will have to pay and get a prescription for the weekly injectable.

Calocurb CEO Sarah Kennedy told Ryan Bridge that people need to be aware of both the cost of the drug and the side effect.

She says that over 70% of people using Wegovy will have gastrointestinal problems that range from nausea to diarrhoea, and over 70% of people regain the weight within a year.

Kennedy says lifestyle changes need to be made as well as taking the drug.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

4104 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play